• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Adverse Event Without Identified Device or Use Problem (2993); Non Reproducible Results (4029)
Patient Problems Ischemia Stroke (4418); Insufficient Information (4580)
Event Date 09/26/2021
Event Type  Injury  
Manufacturer Narrative
The customer's meter was requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.Occupation - the occupation is patient/consumer.
 
Event Description
It was alleged that a patient had a stroke on (b)(6) 2021.The patient was allegedly using coaguchek xs meter serial number (b)(4) at the time of the event.The patient's therapeutic range is reported to be 2.0 - 3.0 inr.It was not known if this was the therapeutic range on the date of the alleged event.The stroke was reported to be a blood clot in the patient's brain.It is not known what diagnostics were used to diagnose the stroke.It is not known if the patient's carotid artery was checked.The patient was reported to be in the intensive care unit of the hospital for 4 days and was hospitalized for one month.It is not known what the patient's inr laboratory results were while hospitalized.The meter inr results leading up to the stroke are not known.It is not known if any changes had been made to the patient's warfarin medication or if there were changes in the patient's lifestyle leading up to the stroke.It was reported that the patient was tested every other week leading up to the stroke and now tests weekly.It was reported that the patient was given medication at the hospital to break up the clot.It is not known if there was any other treatment provided to the patient.It was reported that the patient is currently stable and at home.The reporter was questioning whether the patient's memory may have been affected by the stroke.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
The customer's meter was returned for investigation where it was tested using retention test strips (lot 54145311, expiration date = 30-nov-2022) and retention controls.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.5 inr.Qc 2: 5.3 inr.Qc 3: 5.5 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.It was reported that the patient does not test within 15 seconds of pricking their finger.When using capillary blood apply the sample to the test strip within 15 seconds after lancing the fingertip and within 30 seconds when using venous blood.The patient is taking lovenox.Per product labeling, the coaguchek xs pt test is insensitive to low molecular weight heparins (lmwh) up to 2 iu/ml antifactor xa activity.
 
Manufacturer Narrative
The device code has been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15588992
MDR Text Key301592928
Report Number1823260-2022-03133
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 11/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LOSARTAN.; LOVENOX.
Patient Outcome(s) Hospitalization;
Patient Age52 YR
Patient SexFemale
Patient Weight116 KG
-
-